Close
Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Home
Menu
JOIN
SI Premium
Ratings
Mergers
Earnings
Dividends
IPOs
Hedge Funds
Premium Letters
Send a Tip
API/Data
JOIN
SI Premium
Full Feed View
Headline View
SI Premium Squawk Box
Alerts
Custom Headlines
Upgrade Your Current Account
API
Calendars
Co. NDR/Event Calendar
Dividend Calendar
Earnings Calendar
Event Driven
FDA Calendar
Investor Conferences
IPO Calendar
Merger Arb
Ratings Calendar
Stock Split Calendar
Ratings
Analyst Comments
Hot Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades
New Coverage News
Hot New Coverage
Upgrade News
Hot Upgrades
More...
Mergers
Merger News
Hot M&A News
Private Equity
Rumors
SPAC News
Spinoffs
Merger Arbitrage
Event Driven
2021 Top M&A Deals
Top 50 Takeover Targets
More...
Earnings
Earnings Calendar
Earnings News
Hot Earnings
Guidance
Hot Guidance
Conference Calls
Earnings History Search
More...
Dividends
Dividend Calendar
Dividend News
Hot Dividends
Dividend Hike
Special Dividends
Stock Buybacks
Hot Stock Buybacks
Stock Splits
More...
IPOs
IPO News
Hot IPOs
Equity Offerings
Recent IPOs
Upcoming IPOs
2021 Top IPOs
More...
Hedge Funds
13D
13F
13G
Hedge Funds News
Hot Insider Trades
Insider Trades
More...
Premium Letters
Pulse Picks
Stealth Growth Insider
Send a Tip
API/Data
QUICK LINKS :
Goldman Sachs Conviction Buy List
Warren Buffett News
Elliott Management News
Follow @Street_Insider
Alkermes plc (ALKS) Commences ALKS 3831 Metabolic Profile Study as Schizophrenia Treatment
Article
Related Press Releases (
1
)
Stock Quotes (1)
FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
StreetInsider.com Top Tickers, 4/16/2024
1.
GS
2.
JNJ
3.
SPY
4.
BK
5.
UNH
6.
TSLA
7.
MSFT
8.
BAC
9.
SCHW
10.
MS
Top News
Most Read
Special Reports
Dow futures up on UnitedHealth boost; bond yields, Mideast tensions weigh
UnitedHealth to take up to $1.6 billion hit from Change Healthcare hack this year
Morgan Stanley's profit beats as investment banking rebounds
Johnson & Johnson (JNJ) posts mixed results, narrows full-year guidance
Stocks sag, dollar up as 'higher for longer' rate view takes root
Trump Media & Technology Group (DJT) Files S-1
Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
The Israeli Air Force Has Completed Its Preparation For An Imminent Attack Against Iran - Reuters
Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
After-hours movers: Alpine Immune Sciences, Costco, and more
Go back to Alkermes plc (ALKS) Commences ALKS 3831 Metabolic Profile Study as Schizophrenia Treatment
